Fluorescence spectroscopy to diagnose hepatic steatosis in a rat model of fatty liver

Liver International

Volumn 29, Issue 3, 2009, Pages 331-336

  de Oliveira, Gustavo Ribeiro ^a   Sankarankutty, Ajith K ^a   Castro e Silva, Orlando ^a   Ferreira, Juliana ^a   Kurachi, Cristina ^a   Zucoloto, Sergio ^a   Vannucchi, Hélio ^a   Jordão Jr , Alceu Afonso ^a   Marchini, Júlio Sergio ^a   Bagnato, Vanderlei Salvador ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diagnosis; Laser induced fluorescence; Liver; Spectroscopy; Steatosis

Indexed keywords

LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL RAT; FAT CONTENT; FATTY LIVER; FLUORESCENCE SPECTROSCOPY; HISTOPATHOLOGY; LIPID DIET; LIPID LIVER LEVEL; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; RAT;

ANIMALS; FATTY LIVER; LASERS; RATS; SPECTROMETRY, FLUORESCENCE;

EID: 59849086121     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01878.x     Document Type: Article

References (44)

1. Briceno J, Marchal T, Padillo J, et al. Influence of marginal donors on liver preservation injury. Transplantation 2002; 74: 522-6.
2. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20(Part 1): 829-38.
3. Mor E, Klintmalm GB, Gonwa TA, et al. The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation 1992; 53: 383-6.
4. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55: 807-13.
5. Todo S, Demetris AJ, Makowka L, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903-5.
6. D'Alessandro AM, Kalayoglu M, Sollinger HW, et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transpl Proc 1991; 23(Part 2): 1536-7.
7. Kim SH, Lee JM, Han JK, et al. Hepatic macrosteatosis: Predicting appropriateness of liver donation by using MR imaging - correlation with histopathologic findings. Radiology 2006; 240: 116-29.
8. Selzner N, Selzner M, Jochum W, et al. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol 2006; 44: 694-701.
9. Russo FP, Galligioni A, Calabrese F, et al. Histological features of donor grafts for orthotopic liver transplantation. Transpl Proc 2001; 33: 1177-8.
10. Markin RS, Wisecarver JL, Radio SJ, et al. Frozen section evaluation of donor livers before transplantation. Transplantation 1993; 56: 1403-9.
11. Canelo R, Braun F, Sattler B, et al. Is a fatty liver dangerous for transplantation? Transpl Proc 1999; 31: 414-5.
12. Chui AK, Haghighi K, Painter D, et al. Donor fatty (steatotic) liver allografts in orthotopic liver transplantation. Transpl Proc 1998; 30: 3286-7.
13. Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 1246-51.
14. Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003; 9: 500-5.
15. Bottiroli G, Croce AC. Autofluorescence spectroscopy of cells and tissues as a tool for biomedical diagnosis. Photochem Photobiol Sci 2004; 3: 189-210.
16. Wagnieres GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol 1998; 68: 603-32.
17. Andersson-Engels S, Johansson J, Svanberg K, Svanberg S. Fluorescence imaging and point measurements of tissue: Applications to the demarcation of malignant tumors and atherosclerotic lesions from normal tissue. Photochem Photobiol 1991; 53: 807-14.
18. Huang Z, Zheng W, Xie S, et al. Laser-induced autofluorescence microscopy of normal and tumor human colonic tissue. Int J Oncol 2004; 24: 59-63.
19. Bohorfoush AG. New diagnostic methods for esophageal carcinoma. Recent Results Cancer Res 2000; 155: 55-62.
20. Bohorfoush AG. Tissue spectroscopy for gastrointestinal diseases. Endoscopy 1996; 28: 372-80.
21. Zaak D, Stepp H, Baumgartner R, et al. Ultraviolet-excited (308nm) autofluorescence for bladder cancer detection. Urology 2002; 60: 1029-33.
22. Panjehpour M, Julius CE, Phan MN, Vo-Dinh T, Overholt S. Laser-induced fluorescence spectroscopy for in vivo diagnosis of non-melanoma skin cancers. Lasers Surg Med 2002; 31: 367-73.
23. Anastassopoulou N, Arapoglou B, Demakakos P, et al. Spectroscopic characterisation of carotid atherosclerotic plaque by laser induced fluorescence. Lasers Surg Med 2001; 28: 67-73.
24. Kusunoki Y, Imamura F, Uda H, Mano M, Horai T. Early detection of lung cancer with laser-induced fluorescence endoscopy and spectrofluorometry. Chest 2000; 118: 1776-82.
25. Arnault I, Bao YM, Sebagh M, et al. Beneficial effect of pentoxifylline on microvesicular steatotic livers submitted to a prolonged cold ischemia. Transplantation 2003; 76: 77-83.
26. Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transpl Proc 1991; 23(Part 2): 1538-40.
27. Melo CA, Kurachi C, Grecco C, et al. Pharmacokinetics of photogem using fluorescence monitoring in Wistar rats. J Photochem Photobiol B-Biol 2004; 73: 183-8.
28. AOAC. AOAC Official Method 963.15 -Fat in Ca cao Products (Chap 31:10), Vol. 2. Europe: AOAC International, 1995.
29. Marsman H, Matsushita T, Dierkhising R, et al. Assessment of donor liver steatosis: Pathologist or automated software? Hum Pathol 2004; 35: 430-5.
30. Garcia Ureña MA, Colina Ruiz-Delgado F, Moreno Gonzalez E, et al. Hepatic steatosis in liver transplant donors: Common feature of donor population? World J Surg 1998; 22: 837-44.
31. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-63.
32. Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001; 7: 409-14.
33. Urena MA, Ruiz-Delgado FC, Gonzalez EM, et al. Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transpl Proc 1998; 30: 3288-91.
34. Yoong KF, Gunson BK, Neil DA, et al. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transpl Proc 1999; 31: 550-1.
35. Kalayoglu M, Sollinger HW, Stratta RJ, et al. Extended preservation of the liver for clinical transplantation. Lancet 1988; 1: 617-9.
36. Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 1999; 68: 780-4.
37. Seifalian AM, Chidambaram V, Rolles K, Davidson BR. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 1998; 4: 71-7.
38. Melo CAS, Lima AL, Brasil IR, et al. Characterization of light penetration in rat tissues. J Clin Laser Med Surg 2001; 19: 175-9.
39. Sankarankutty AK, Castro e Silva O Jr, Ferreira J, et al. Use of laser auto-fluorescence for evaluating liver grafts. Laser Phys Lett 2006; 3: 539-45.
40. Beuthan J, Minet O, Muller G. Quantitative optical biopsy of liver tissue ex vivo. IEEE J Sel Top Quant Electron 1996; 2: 906-13.
41. Vollet Filho JD. Identificação e quantificação de fotossensibilizador em tecido hepático por espectroscopia de fluorescência e sua importância na terapia fotodinâmica, in Instituto de Física de São Carlos-IFSC, 2007, Universidade de São Paulo -USP, São Carlos, p. 95f.
42. Sugioka G, Porta EA, Corey PN, Hartroft WS. The liver of rats fed riboflavin-deficient diets at two levels of protein. Am J Pathol 1969; 54: 1-19.
43. Palmer DN, Husbands DR, Winter PJ, Blunt JW, Jolly RD. Ceroid lipofuscinosis in sheep. I. Bis(monoacylglycero)phosphate, dolichol, ubiquinone, phospholipids, fatty acids, and fluorescence in liver lipopigment lipids. J Biol Chem 1986; 261: 1766-72.
44. Du C, Sato A, Watanabe S, et al. Cholesterol synthesis in mice is suppressed but lipofuscin formation is not affected by long-term feeding of n-3 fatty acid-enriched oils compared with lard and n-6 fatty acid-enriched oils. Biol Pharm Bull 2003; 26: 766-70.